SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Forecast, Price Target & Analyst Ratings
NASDAQ:SCNI • US09073Q3039
0.78 USD
-0.03 (-4.06%)
At close: Mar 6, 2026
0.75 USD
-0.03 (-3.85%)
After Hours: 3/6/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCINAI IMMUNOTHERAPEUTICS LT (SCNI).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.78 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
SCNI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SCNI.
In the previous month the buy percentage consensus was at a similar level.
SCNI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 658K | |||
| EBITDA YoY % growth | -10.499M -4.62% | -9.192M 12.45% | -6.989M 23.97% | |
| EBIT YoY % growth | -11.061M -2.58% | -9.706M 12.25% | -8.638M 11.00% | |
| Operating Margin | N/A | N/A | -1,312.77% | |
| EPS YoY % growth | N/A 99.93% | -18.70 -61,011.11% | N/A 98.91% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A